Cengild Medical Berhad (KLSE:CENGILD)

Malaysia · Delayed Price · Currency is MYR

0.2000

+0.0050 (2.56%)

At close: Jul 6, 2026

-13.04% (1Y)

Market Cap	166.58M -18.4%
Revenue (ttm)	73.15M -4.5%
Net Income	9.41M -9.2%
EPS	0.01 -9.1%
Shares Out	832.91M
PE Ratio	16.26
Forward PE	n/a
Dividend	0.01 (4.85%)
Ex-Dividend Date	Feb 25, 2026

Volume	39,500
Open	0.1950
Previous Close	0.1950
Day's Range	0.1950 - 0.2000
52-Week Range	0.1950 - 0.2750
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric su... [Read more]

Industry Health Services

Founded 2017

Employees 151

Stock Exchange Bursa Malaysia

Ticker Symbol CENGILD

Full Company Profile

Financial Performance

In fiscal year 2025, Cengild Medical Berhad's revenue was 80.00 million, an increase of 19.72% compared to the previous year's 66.82 million. Earnings were 11.06 million, a decrease of -0.19%.

Financial Statements